Hospital
Albany General Hospital
Albany General Hospital was paid $25.57M by Medicaid between Jan 2018 and Dec 2024, across 111 billing codes. Its largest line is 99284, emergency room visit (serious) — 30% of everything it billed.
33Billing provider infoALBANY GENERAL HOSPITAL
ALBANY, OR 97321
ALBANY, OR 97321
33aNPI1154372340assigned 05/13/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$25.57M
24GClaims381,750
24DCodes billed111
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Oregon
Rank by total paid#6 of 17
Median peer was paid$13.35M
This provider vs. median1.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 52,130 | $3.48M | |
| 2019 | 53,593 | $3.97M | |
| 2020 | 46,082 | $3.35M | |
| 2021 | 53,466 | $3.49M | |
| 2022 | 58,013 | $3.70M | |
| 2023 | 56,994 | $3.44M | |
| 2024incomplete | 61,472 | $4.15M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 30% | 29,027 | 24,456 | $7.61M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 29% | 40,421 | 33,859 | $7.40M |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 7.0% | 2,499 | 2,094 | $1.80M |
| 95811 | 5.3% | 2,007 | 1,671 | $1.35M | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.0% | 3,710 | 3,341 | $1.27M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.3% | 6,122 | 5,548 | $846K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.0% | 7,296 | 6,119 | $766K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.9% | 11,408 | 10,325 | $486K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.8% | 10,278 | 6,847 | $457K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.6% | 3,041 | 1,134 | $399K |
| 71045 | Radiologic examination, chest; single view | 1.5% | 7,175 | 6,408 | $373K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.1% | 949 | 866 | $276K |
99 more codes
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 436 | $193K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,627 | $192K |
| G0330 | Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room | <1% | 124 | $165K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,553 | $159K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 811 | $145K |
| 81514 | <1% | 459 | $110K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,275 | $109K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,124 | $104K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,879 | $102K |
| 80053 | Comprehensive metabolic panel | <1% | 39,020 | $97K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 654 | $86K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 6,282 | $76K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,978 | $70K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 926 | $65K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,100 | $62K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,831 | $57K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,830 | $57K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,911 | $55K |
| 86850 | <1% | 2,709 | $54K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 7,157 | $49K |
| 86900 | <1% | 623 | $47K | |
| 97602 | <1% | 459 | $42K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 34,882 | $36K |
| 80061 | Lipid panel | <1% | 3,383 | $34K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,066 | $32K |
| 85027 | <1% | 5,963 | $28K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 2,951 | $27K |
| 36415 | Collection of venous blood by venipuncture | <1% | 40,143 | $27K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,750 | $27K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,333 | $22K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 198 | $21K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 146 | $19K |
| 88142 | <1% | 1,026 | $18K | |
| 86780 | <1% | 1,606 | $17K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 720 | $15K |
| 87800 | <1% | 348 | $14K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 679 | $13K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 206 | $11K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,524 | $11K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 12 | $10K |
| 95805 | <1% | 12 | $6K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 25 | $5K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 120 | $5K |
| 82728 | <1% | 439 | $5K | |
| 97597 | <1% | 45 | $4K | |
| 87340 | <1% | 470 | $4K | |
| 86803 | <1% | 317 | $4K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 575 | $4K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 53 | $3K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 25 | $3K |
| 82607 | <1% | 190 | $2K | |
| 84702 | <1% | 174 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 11,181 | $2K |
| 93922 | <1% | 27 | $2K | |
| 83550 | <1% | 276 | $2K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 36 | $2K |
| 84703 | <1% | 1,119 | $2K | |
| 86762 | <1% | 141 | $2K | |
| 83540 | <1% | 276 | $1K | |
| 83525 | <1% | 170 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,934 | $1K |
| 95800 | <1% | 12 | $1K | |
| 84439 | <1% | 156 | $1K | |
| 82746 | <1% | 81 | $896.70 | |
| 87653 | <1% | 30 | $831.63 | |
| 87522 | Neg quan hep c or qual rna | <1% | 26 | $823.48 |
| A9270 | Non-covered item or service | <1% | 4,407 | $766.04 |
| 99223 | Prolong inpt eval add15 m | <1% | 12 | $752.71 |
| 82105 | <1% | 52 | $751.41 | |
| 81001 | <1% | 19,625 | $571.49 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 78 | $547.11 |
| 87081 | <1% | 75 | $425.95 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 13 | $369.20 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,106 | $293.27 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 14 | $240.11 |
| 80306 | <1% | 2,912 | $201.98 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,373 | $200.08 |
| 87420 | <1% | 45 | $153.01 | |
| 83690 | <1% | 7,595 | $116.22 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,033 | $114.43 |
| 87077 | <1% | 151 | $105.04 | |
| 87186 | <1% | 117 | $103.80 | |
| 85652 | <1% | 43 | $97.38 | |
| 84484 | <1% | 4,729 | $62.75 | |
| 81025 | <1% | 2,715 | $49.05 | |
| 81002 | <1% | 313 | $19.64 | |
| 90686 | <1% | 15 | $15.68 | |
| 85610 | <1% | 917 | $8.71 | |
| 83880 | <1% | 515 | $5.33 | |
| 83735 | <1% | 2,920 | $1.26 | |
| 82948 | <1% | 434 | $0.83 | |
| 86901 | 0% | 624 | $0.00 | |
| 83605 | 0% | 952 | $0.00 | |
| 85379 | 0% | 123 | $0.00 | |
| 82803 | 0% | 115 | $0.00 | |
| 85730 | 0% | 56 | $0.00 | |
| 87040 | 0% | 62 | $0.00 | |
| 74018 | 0% | 31 | $0.00 | |
| 72125 | Computed tomography, cervical spine; without contrast material | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKETERI, DANIEL (CEO-SAGH)
| Provider | Location | Paid |
|---|---|---|
| Albany General Hospital | Albany, OR | $2.40M |
| Albany General Hospital | Albany, OR | $1.02M |
| Albany General Hospital | Albany, OR | $569K |
| Albany General Hospital | Albany, OR | $79K |
| Albany General Hospital | Albany, OR | $37K |
| Albany General Hospital | Albany, OR | $14K |
| Albany General Hospital | Albany, OR | $668.86 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.